Real-time global intelligence

© 2026 OpenWatch. All rights reserved.

For informational and entertainment purposes only. Not investment advice.

Platform

Brief
Signals
Countries
Companies
Industries
Themes
Scenarios
Rankings

Tools

Globe
Analytics
Crises
Clusters
Supply Chain
Alliances
Screener
Watchlist
Portfolio

Developer

API Reference
Developer Keys
Webhooks
Status

Sources

View all sources →

1,000+ tracked sources

Signals updated every 15 minutes

Not investment advice. OpenWatch is provided for informational and entertainment purposes only. While we strive for accuracy, precision, and source attribution in all intelligence assessments, geopolitical analysis involves inherent uncertainty and our conclusions may be incomplete, delayed, or incorrect. Nothing on this platform constitutes financial, investment, legal, or professional advice of any kind. Forward-looking scenarios and probability estimates are analytical hypotheses — not independently validated forecasts. Any actions taken based on information found here are solely your responsibility. Always consult a qualified financial advisor before making investment decisions. Past signal patterns do not guarantee future outcomes.

Methodology
Privacy Policy
Terms of Use

openwatch.io

v·73d148f

Signal Search

Search across all ingested intelligence signals. Supports websearch syntax: AND OR "exact phrase" -exclude

Keywords

Threat Layer

Military Cyber Economic Disaster Political Criminal Health Supply Chain

Signal Type

Any Crisis Update Resolution

Region

Country

Min. Severity

Any ≥ 3 ≥ 5 ≥ 7 ≥ 9

Date Range

Clear all filters

Sort by

Severity Newest

↓Export CSV (requires API key)

4 results for "Pharmaceuticals"

Page 1 of 1

PoliticalUpdate🇺🇸United States21d ago

Regeneron Pharmaceuticals rejected overtures in New York [3 sources]

6.4/10·GDELT Events Historical

Source ↗Details →

PoliticalUpdate13d ago

Regeneron Pharmaceuticals criticized Limerick [10 sources]

5.8/10·GDELT Events Historical

Source ↗Details →

PoliticalUpdate🇺🇸United States7d ago

Indian firms commit record 20.5 billion dollars investments in US at SelectUSA Summit New Delhi, May 06:  Indian companies have announced a record $20.5 billion in investments in the United States at the 2026 SelectUSA Investment Summit in Maryland, underscoring deepening economic ties between the two countries. According to the U.S. Embassy in New Delhi, the investments span key sectors such as pharmaceuticals, advanced manufacturing, energy infrastructure and emerging technologies, and are expected to create thousands of jobs while strengthening supply chains.

3.5/10·Greater Kashmir

Source ↗Details →

MilitaryUpdate31d ago

U.S. supply chains with connections to Xinjiang and the Chinese military are heavily regulated — just not for pharmaceuticals. The post How Big Pharma’s China Trials Are Escaping Scrutiny appeared first on The Wire China .

3.1/10·The Wire China

Source ↗Details →